Beximco Pharmaceuticals Limited Sponsored GDR RegS’s (R2WA) Moving Averages Convergence Divergence (MACD) indicator is <0.01, suggesting Beximco Pharmaceuticals Limited Sponsored GDR RegS is a Buy.
Beximco Pharmaceuticals Limited Sponsored GDR RegS’s (R2WA) 20-Day exponential moving average is 0.63, while Beximco Pharmaceuticals Limited Sponsored GDR RegS’s (R2WA) share price is €0.60, making it a Sell.
Beximco Pharmaceuticals Limited Sponsored GDR RegS’s (R2WA) 50-Day exponential moving average is 0.61, while Beximco Pharmaceuticals Limited Sponsored GDR RegS’s (R2WA) share price is €0.60, making it a Buy.
Beximco Pharmaceuticals Limited Sponsored GDR RegS’s (R2WA) 10-Day exponential moving average is 0.63, while Beximco Pharmaceuticals Limited Sponsored GDR RegS’s (R2WA) share price is €0.60, making it a Sell.
Beximco Pharmaceuticals Limited Sponsored GDR RegS’s (R2WA) 100-Day exponential moving average is 0.58, while Beximco Pharmaceuticals Limited Sponsored GDR RegS’s (R2WA) share price is €0.60, making it a Buy.
Beximco Pharmaceuticals Limited Sponsored GDR RegS’s (R2WA) stock price is €0.60 and Beximco Pharmaceuticals Limited Sponsored GDR RegS’s (R2WA) 50-day simple moving average is 0.62, creating a Buy signal.
Beximco Pharmaceuticals Limited Sponsored GDR RegS’s (R2WA) stock price is €0.60 and Beximco Pharmaceuticals Limited Sponsored GDR RegS’s (R2WA) 100-day simple moving average is 0.57, creating a Buy signal.
Beximco Pharmaceuticals Limited Sponsored GDR RegS’s (R2WA) stock price is €0.60 and Beximco Pharmaceuticals Limited Sponsored GDR RegS’s (R2WA) 200-day simple moving average is 0.51, creating a Buy signal.